PMID- 28182687 OWN - NLM STAT- MEDLINE DCOM- 20170828 LR - 20190208 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 12 IP - 2 DP - 2017 TI - Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production. PG - e0171969 LID - 10.1371/journal.pone.0171969 [doi] LID - e0171969 AB - Obesity has become a major threat to public health and is accompanied by chronic low-grade inflammation, which leads to various pathological developments. Lunasin, a natural seed peptide, exhibits several biological activities, such as anti-carcinogenesis, anti-inflammatory, and antioxidant activities. However, the mechanism of action of lunasin in obesity-related inflammation has not been investigated. The aim of this study was to explore whether lunasin could reduce the inflammation induced by obesity-related mediators in RAW264.7 cells and 3T3-L1 adipocytes and whether it could attenuate the crosstalk between the two cell lines. RAW264.7 cells were cultured in leptin-containing medium, adipocyte-conditioned medium (Ad-CM), or co-cultured with 3T3-L1 cells to mimic the physiology of obesity. The data showed that the secretion of pro-inflammatory cytokine interleukin-1beta (IL-1beta) was inhibited by lunasin after leptin activation of RAW264.7 cells. In addition, lunasin decreased monocyte chemoattractant protein-1 (MCP-1) and IL-1beta secretions in the Ad-CM model. Cytokine MCP-1, IL-6, tumor necrosis factor (TNF)-alpha, and IL-1beta secretions were significantly decreased by leptin or Ad-CM plus lipopolysaccharide stimulation. Subsequently, the co-culture of the two cells refined the direct relation between them, resulting in apparently increased MCP-1, and decreased IL-6 levels after lunasin treatment. In 3T3-L1 adipocytes, lunasin also exhibited anti-inflammatory property by inhibiting MCP-1, plasminogen activator inhibitor-1, and leptin productions stimulated by (TNF)-alpha, lipopolysaccharide, or RAW264.7 cell-conditioned medium. This result revealed that lunasin acts as a potential anti-inflammatory agent not only in macrophages but also in adipocytes, disrupting the crosstalk between these two cells. Therefore, this study suggests the intake of lunasin from diet or as a supplement, for auxiliary prevention or therapy in obesity-related inflammatory applications. FAU - Hsieh, Chia-Chien AU - Hsieh CC AUID- ORCID: 0000-0003-3993-0144 AD - Department of Human Development and Family Studies, National Taiwan Normal University, Taipei, Taiwan. FAU - Chou, Mei-Jia AU - Chou MJ AD - Department of Human Development and Family Studies, National Taiwan Normal University, Taipei, Taiwan. FAU - Wang, Chih-Hsuan AU - Wang CH AD - Department of Human Development and Family Studies, National Taiwan Normal University, Taipei, Taiwan. LA - eng PT - Journal Article DEP - 20170209 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Cytokines) RN - 0 (Leptin) RN - 0 (Plant Proteins) SB - IM MH - 3T3 Cells MH - Adipocytes/cytology/*drug effects/metabolism MH - Animals MH - Anti-Inflammatory Agents/*pharmacology MH - Cell Differentiation MH - Cytokines/genetics/*metabolism MH - Leptin/genetics/metabolism MH - Mice MH - Obesity/*metabolism MH - Plant Proteins/*pharmacology PMC - PMC5300240 COIS- The authors have declared that no competing interests exist. EDAT- 2017/02/10 06:00 MHDA- 2017/08/29 06:00 PMCR- 2017/02/09 CRDT- 2017/02/10 06:00 PHST- 2016/09/21 00:00 [received] PHST- 2017/01/27 00:00 [accepted] PHST- 2017/02/10 06:00 [entrez] PHST- 2017/02/10 06:00 [pubmed] PHST- 2017/08/29 06:00 [medline] PHST- 2017/02/09 00:00 [pmc-release] AID - PONE-D-16-37846 [pii] AID - 10.1371/journal.pone.0171969 [doi] PST - epublish SO - PLoS One. 2017 Feb 9;12(2):e0171969. doi: 10.1371/journal.pone.0171969. eCollection 2017.